EYEPOINT PHARMACEUTICALS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.458 EUR | -0.33% |
|
-14.99% | -60.78% |
Chart calendar EyePoint Pharmaceuticals, Inc.
5ec4b2aab2ba86b.Tm9TO6i6UpwuWKVYoFxMMp1dK8IPo6w2045pop5FvRs.BFclcc7qJ69UG_E972g7cN4EXIQi6v56prs24NEz7i4HXmd58NYc-WIpkQ~305dcffefc80452077bfcd1a5003c28c
Upcoming events on EyePoint Pharmaceuticals, Inc.
Past events on EyePoint Pharmaceuticals, Inc.
| 08/05/2024 12:00 | Q1 2024 Earnings Release |
| 06/05/2024 13:00 | DURAVYU™ Phase 2 PAVIA Trial Results Call |
| 13/03/2024 13:15 | Guggenheim Healthy Altitudes Summit |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 07/03/2024 13:30 | Q4 2023 Earnings Call |
| 07/03/2024 12:00 | Q4 2023 Earnings Release |
| 05/03/2024 15:30 | TD Cowen Health Care Conference |
| 07/02/2024 17:30 | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 10/01/2024 18:30 | JPMorgan Healthcare Conference |
| 04/12/2023 13:00 | DAVIO 2 Phase 2- Trial Results Call |
| 09/11/2023 13:00 | Investor Meeting - Key Opinion Leader |
| 07/11/2023 19:30 | Guggenheim Securities Inflammation & Immunology Conference |
| 03/11/2023 15:00 | American Academy Of Ophthalmology Meeting |
| 02/11/2023 15:10 | Eyecelerator Conference - Panel |
| 01/11/2023 12:30 | Q3 2023 Earnings Call |
| 01/11/2023 11:00 | Q3 2023 Earnings Release |
| 10/10/2023 18:45 | JonesTrading Healthcare Summit |
| 26/09/2023 17:25 | Cantor Global Healthcare Conference - Fireside Chat |
| 13/09/2023 17:50 | Baird Global Healthcare Conference - Fireside Chat |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,4 19,0 7.33% | 34,4 45,6 -24.47% | 36,9 35,2 4.97% | 41,4 41,3 0.31% | 46,0 40,5 13.59% | 43,6 |
|
EBITDA Million USD | Released Forecast Spread | -40,7 -44,8 9.26% | -34,6 -15,0 -130.94% | 0,00 0,00 - | 0,00 0,00 - | 0,00 119 - | 192 |
|
EBIT Million USD | Released Forecast Spread | -47,9 -50,0 4.32% | -37,3 -24,7 -50.96% | -55,3 -52,0 -6.31% | -78,9 -78,6 -0.46% | -75,1 -81,3 7.63% | -131 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -56,8 -59,0 3.82% | -45,4 -36,3 -25.05% | -58,4 -55,2 -5.91% | -102 -82,2 -24.42% | -70,7 -76,6 7.69% | -120 |
|
Net income Million USD | Released Forecast Spread | -56,8 -59,0 3.82% | -45,4 -36,3 -25.05% | -58,4 -55,2 -5.91% | -102 -82,2 -24.42% | -70,8 -76,6 7.56% | -120 |
|
EPS USD | Released Forecast Spread | -5,40 -5,65 4.42% | -3,54 -2,13 -66.04% | -2,03 -1,99 -2.27% | -2,74 -2,19 -25.23% | -1,82 -1,92 5.4% | -2,34 |
| Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,29 9,89 -6% | 11,6 10,9 6.45% | 10,0 10,9 -8.32% | 10,5 10,4 1.25% | 7,68 7,57 1.54% | 9,11 42,1 -78.39% | 15,2 7,43 104.6% | 14,0 8,70 61.18% | 11,7 9,14 27.9% | 9,59 | 9,26 | 8,97 | 10,9 | 10,5 |
|
EBITDA Million USD | Released Forecast Spread | 31,0 | 46,0 | 49,0 | 52,0 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -18,3 -18,5 1.14% | -19,2 -18,8 -2.3% | -18,4 -25,4 27.51% | -23,0 -22,6 -1.95% | -21,6 -25,2 14.42% | -22,8 4,77 -577.27% | -14,4 -20,1 28.26% | -16,4 -22,3 26.68% | -33,3 -21,9 -51.88% | -29,4 | -31,9 | -35,0 | -22,4 | -25,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,0 -19,3 -8.59% | -19,4 -19,1 -1.84% | -18,4 -25,2 26.95% | -43,5 -23,4 -85.83% | -21,2 -25,9 18.43% | -22,9 12,4 -284.93% | -12,6 -18,7 32.43% | -14,0 -19,9 29.44% | -29,3 -19,2 -52.54% | -27,2 | -30,0 | -33,5 | -22,4 | -25,4 |
|
Net income Million USD | Released Forecast Spread | -21,0 -19,3 -8.59% | -19,4 -19,1 -1.84% | -18,4 -25,2 26.95% | -43,5 -23,4 -85.83% | -21,2 -25,9 18.43% | -22,9 12,4 -284.93% | -12,6 -18,7 32.43% | -14,1 -19,9 29.03% | -29,3 -19,2 -52.54% | -27,2 | -30,0 | -33,5 | -22,4 | -25,4 |
|
EPS USD | Released Forecast Spread | -0,56 -0,56 0% | -0,52 -0,51 -1.96% | -0,49 -0,65 25.08% | -1,16 -0,62 -88.31% | -0,56 -0,69 18.45% | -0,61 0,57 -207.02% | -0,33 -0,48 31.72% | -0,33 -0,49 32.26% | -0,55 -0,38 -45.93% | -0,53 | -0,59 | -0,66 | -0,45 | -0,48 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 02/03/23 | 03/05/23 | 02/08/23 | 01/11/23 | 07/03/24 | 08/05/24 | - | - | - | - | - |
More events
Past sector events for EyePoint Pharmaceuticals, Inc.
| 30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:44 | ALKEM LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 09:10 | IPCA LABORATORIES LIMITED: Q4 2024 Earnings Release |
| 28/05/2024 | PFIZER LIMITED: Q4 2024 Earnings Release |
| 27/05/2024 | DOTTIKON ES HOLDING AG: Q4 2024 Earnings Release |
| 27/05/2024 13:10 | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EYPT Stock
- PV3B Stock
- Calendar EyePoint Pharmaceuticals, Inc.
